Breaking News

FDA Gives Go Ahead to Brain Wave Test for Assessing ADHD in Children
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

On Monday, the U.S. Food and Drug Administration (FDA) announced that it has approved the first brain wave test that would help to assess attention-deficit/hyperactivity disorder, commonly known as ADHD, in children and in adolescents 6-17 years of age.

The groundbreaking test is called the Neuropsychiatric EEG-Based Assessment Aid (NEBA) System. It uses electroencephalogram technology to find out the ratio between two standard brain wave frequencies, theta and beta. Particular combinations of these two brain wave frequencies are more prevalent in children and adolescents with ADHD, while such combinations aren’t so prevalent in children without ADHD.

  
What
Where


The new brain wave test cleared by the FDA is non-invasive and takes about 15 to 20 minutes to complete. However, the FDA has issued guidance that the test is not to be accepted as a standalone arbiter in the case of ADHD diagnosis, but should be used to confirm an ADHD diagnosis where medical and psychological examinations suggest presence of the disorder.

Christy Foreman, director of the Office of Device Evaluation of the FDA’s Center for Devices and Radiological Health said, “Diagnosing ADHD is a multistep process based on a complete medical and psychiatric exam … The NEBA System along with other clinical information may help health care providers more accurately determine if ADHD is the cause of a behavioral problem.”

ADHD is an extremely common neurobehavioral disorder among children and adolescents, and about 9.5 percent of those between the ages of 4 and 17 were found affected by ADHD according to a 2007 survey of the Centers for Disease Control and Prevention.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




According to the announcement made by FDA, the NEBA system would go a long way in helping to diagnose ADHD. An independent group of ADHD experts who reviewed the approval process said, “the use of the NEBA System aided clinicians in making a more accurate diagnosis of ADHD when used in conjunction with a clinical assessment.”





 

RELEVANT JOBS

Director & Associate General Counsel - Litigation

USA-DC-Washington

How You’ll Contribute The Legal and Business Affairs (LBA) team assists the organization in...

Apply now

VP & Sr. Associate General Counsel, Technology, Operations & Facilities

USA-DC-Washington

How You’ll Contribute The Legal and Business Affairs (LBA) team assists the organization in...

Apply now

Associate Attorney

USA-NJ-Florham Park

Job Description The Law Office of Barry E. Janay, P.C. is a growing law firm with a focus on...

Apply now

Family Law Attorney

USA-OK-Yukon

Bedlam Law is looking for an exceptionally dynamic, highly motivated, self-starter with at least fiv...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Corporate/Transactional Attorney

USA-IA-Des Moines

Des Moines office of a BCG Attorney Search Top Ranked Law Firm seeks corporate/transactional attorne...

Apply Now

Corporate Attorney / Counsel

USA-NY-New York City

New York City office of a BCG Attorney Search Top Ranked Law Firm seeks corporate attorney with 5+ y...

Apply Now

Housing Finance Associate Attorney

USA-MN-Minneapolis

Minneapolis office of a BCG Attorney Search Top Ranked Law Firm seeks a housing finance associate at...

Apply Now

Most Popular

SEARCH IN ARCHIVE

To Top